NSB 2.94% 3.5¢ neuroscientific biopharmaceuticals ltd

Ann: Appendix 4C - quarterly, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 81 Posts.
    lightbulb Created with Sketch. 7
    my thoughts:
    1. nice to get an update on the toxicology. I guess in summary it has been completed, pending actually analysing the result and receiving the report. Fingers crossed for soon!

    2. sounds like they are also progressing other studies in rabbits which is interesting.

    3. NSB are somewhat bulletproof with those cash reserves on hand.

    4. I think from here on out there should be a steady stream of announcements flowing on updates and increased investor support as we become more "operational"

    To conclude, I would have liked the tox results by now, but I'll take a chance to quote warren buffet - the share market is simply a mechanism for the transference of wealth from the impatient to the patient. Company may be moving a little slow but are in a rock solid position, I'm personally a longer term investor so not too bothered atm, expecting a steady rise over the next 6 weeks.
 
watchlist Created with Sketch. Add NSB (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.001(2.94%)
Mkt cap ! $5.061M
Open High Low Value Volume
3.4¢ 3.5¢ 3.4¢ $4.948K 144.2K

Buyers (Bids)

No. Vol. Price($)
1 2642 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 7949 1
View Market Depth
Last trade - 15.41pm 30/09/2024 (20 minute delay) ?
NSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.